Conventional MRI in multiple sclerosis

Journal of Neuroimaging

Volumn 17, Issue SUPPL. 1, 2007, Pages

  Filippi, Massimo ^a   Rocca, Maria A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Clinical correlates; Diagnosis; Magnetic resonance imaging; Multiple sclerosis; T1 weighted lesions; T2 weighted lesions

Indexed keywords

CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MICROORGANISM DETECTION; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW;

CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34147186324     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00129.x     Document Type: Review

References (64)

1. Carswell R. Pathological Anatomy. Illustrations of the Elementary Forms of Disease. London: Longman, Orme, Brown, Green and Longman; 1838.
2. Cruveilhier J. Anatomie Pathologique du corps humain: descriptions avec figures lithographiées et coloriées: des diverses alterations morbides dont le corps humain est susceptible. JB Balliere, 1842, Paris.
3. Young IR, Hall AS, Pallis CA, et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981;2:1063-1066.
4. Stewart WA, Hall LD, Berry K, Paty DW. Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet 1984;2:412.
5. Ormerod IE, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987;110:1579-1616.
6. Isaac C, Li DK, Genton M, et al. Multiple sclerosis: A serial study using MRI in relapsing patients. Neurology 1988;38:1511-1515.
7. Grossman RI, Gonzalez-Scarano F, Atlas SW, et al. Multiple sclerosis: Gadolinium enhancement in MR imaging. Radiology 1986;161:721-725.
8. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-939.
9. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-669.
10. Miller DH, Barkhof F, Nauta JJ. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993;116:1077-1094.
11. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995;195:725-732.
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
13. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988;38:1822-1825.
14. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-185.
15. Bastianello S, Bozzao A, Paolillo A, et al. Fast spin-echo and fast fluid-attenuated inversion recovery sequences versus conventional spin-echo for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol 1997;18:699-704.
16. Filippi M, Horsfield MA, Rovaris M, et al. Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis. AJNR Am J Neuroradiol 1998;19:239-244.
17. Gawne-Cain ML, O'Riordan JI, Coles A, et al. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: A comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosurg Psychiatry 1998;64:197-203.
18. Filippi M, Rovaris M, Capra R, et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 1998;121:2011-2020.
19. Silver NC, Good CD, Barker GJ, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 1997;120:1149-1161.
20. Bastianello S, Gasperini C, Paolillo A, et al. Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast. AJNR Am J Neuroradiol 1998;19:1863-1867.
21. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288.
22. Gass A, Filippi M, Rodegher ME, et al. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI. Neurology 1998;50:548-550.
23. Bakshi R, Ariyaratana S, Benedict RHB, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001;58:742-748.
24. Filippi M, Horsfield MA, Ader HJ, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:499-506.
25. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
26. Barkhof F, Filippi M, van Waesberghe JH, et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 1997;49:1682-1688.
27. Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-697.
28. Charil A, Zijdenbos AP, Taylor J, et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003;19:532-544.
29. Filippi M, Grossman RI. MI techniques to monitor MS evolution. The present and the future. Neurology 2002;58:1147-1153.
30. Li DK, Held U, Petkau J, et al. MRI T2 lesion burden in multiple sclerosis: A plateauing relationship with clinical disability. Neurology 2006;66:1384-1389.
31. Filippi M, Horsfield MA, Morrissey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994;44:635-641.
32. Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-164.
33. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4:281-288.
34. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608.
35. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588-594.
36. Tubridy N, Coles AJ, Molyneux P, et al. Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. Brain 1998;121:225-231.
37. Kidd D, Thorpe JW, Kendall BE, et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:15-19.
38. Ingle GT, Sastre-Garriga J, Miller DH, et al. Is inflammation important in early PPMS? A longitudinal MRI study. J Neurol Neurosurg Psychiatry 2005;76:1255-1258.
39. Koudriavtseva T, Thompson AJ, Fiorelli M, et al. Gadolinium enhanced MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:285-287.
40. Molyneux PD, Filippi M, Barkhof F, et al. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 1998;43:332-339.
41. Simon JH. From enhancing lesions to brain atrophy in MS. J Neuroimmunol 1999;98:7-15l.
42. Stone LA, Smith E, Albert PS, et al. Blood-brain barrier disruption on contrast enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender and age. Neurology 1995;45:1122-1126.
43. Losseff N, Kingsley D, McDonald WI, et al. Clinical and magnetic resonance imaging predictors in primary and secondary progressive MS. Mult Scler 1996;1:218-222.
44. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions (black holes) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476.
45. van Walderveen MA, Lycklama ANijeholt GJ, Ader HJ, et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 2001;58:76-81.
46. Camp SJ, Stevenson VL, Thompson AJ, et al. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005;128:2891-2898.
47. Rovaris M, Gallo A, Valsasina P, et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: An in vivo study using diffusion tensor MRI. Neuroimage 2005;24:1139-1146.
48. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
49. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-2069.
50. Tintoré M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MRI criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000;21:702-706.
51. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002;52:47-53.
52. Tintoré M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003;60:27-30.
53. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-846.
54. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637.
55. Kidd D, Barkhof F, McConnel R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26.
56. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254-260.
57. Drayer B, Burger P, Hurwitz B, et al. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: Increased iron content? AJR Am J Roentgenol 1987;149:357-363.
58. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000;11:15-21.
59. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis:A quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62-68.
60. Tjoa CW, Benedict RH, Weinstock-Guttman B, et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005;234:17-24.
61. Keiper MD, Grossman RI, Hirsch JA, et al. MR identification of white matter abnormalities in multiple sclerosis: A comparison between 1.5 T and 4 T. AJNR Am J Neuroradiol 1998;19:1489-1493.
62. th Scientific Assembly and Meeting; December 5, 2003; Chicago.
63. Sicotte NL, Voskuhl RR, Bouvier S, et al. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol 2003;38:423-427.
64. Erskine MK, Cook LL, Riddle KE, et al. Resolution-dependent estimates of multiple sclerosis lesion loads. Can J Neurol Sci 2005;32:205-212.